NYSE
$126.40▼ 0.21%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $8.07BShares out 63.8M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
18- 9.21After-hours26.09.22 06:088-KKey event#●●●
APTARGROUP, INC.
AptarGroup announced that its Russian subsidiary, OOO Aptar Vladimir, has been placed under temporary external administration following a decree by the President of the Russian Federation on September 21, 2026. As of December 31, 2025, the subsidiary represented less than 0.6% of the company's consolidated net sales and operating income, and less than 1% of its consolidated assets.…more
$126.40-0.21%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.11Regular26.09.12 01:463Ownership
APTARGROUP, INC.
Daniel Ackerman, an insider at AptarGroup, Inc., has filed a Form 3 to report his initial statement of beneficial ownership of securities. This filing serves as a standard disclosure regarding changes in corporate leadership and insider holdings.…more
$126.40-0.21%vs prev closeView filingShare - 9.10After-hours26.09.11 05:068-KKey event
APTARGROUP, INC.
Aditya J. Gandhi, Vice President and Chief Accounting Officer of AptarGroup, will resign effective September 11, 2026. Daniel Ackerman has been appointed as the company's Senior Vice President and Interim Chief Accounting Officer, effective as of the same date.…more
$126.40-0.21%vs prev closeView filingShare
17 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.14After-hours26.10.15 06:05#●●●#●●●
AptarGroup's Aptar Pharma Receives CE Marking for LuerVax
Aptar Pharma has received CE marking under the EU Medical Device Regulation for its LuerVax intranasal delivery device and Spray Divider. This milestone allows the company to further support customers in developing innovative intranasal vaccine solutions.…more
$126.40-0.21%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 9.21After-hours26.09.22 06:19
●●●●●●●● ●●●●● ●●●●●●
AptarGroup's Russian subsidiary has been placed under temporary external administration by a Kremlin decree. The company stated that the subsidiary accounts for less than 0.6% of its net sales and operating income, indicating minimal financial impact.…more
$126.40-0.21%vs prev closeShareBenzinga - 9.14After-hours26.09.15 06:11
●●●●●●●● ●●●●● ●●●●●●
AptarGroup has signed a research collaboration with Massachusetts General Hospital to develop a platform for nose-to-brain drug delivery. The initiative aims to accelerate CNS drug development pipelines, though no specific financial impact was disclosed.…more
$126.40-0.21%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report